An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
Clinical trial NCT00488774 · TERMINATED
Trial details
- NCT number
- NCT00488774
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2009-05-01
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.